b.brandt
TL2 Moderator · Bursa
Contributes reviews on supplier material. Based in Bursa.
Joined 2 February 2025 · last posted 2d
86Posts here
1Topics
0Solutions
1.1kLikes received
811Likes given
22Badges
167Days visited
2.7kPosts read
Recent activity
Full stream-
How shortages have affected compounding permissions Replied, post #72 · Access › Shortages · 26 Jul 2026 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #49 · Clinical › Prescriber conversations · 25 Jul 2026 · 13 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Documenting a supplier's response to a discrepancy Replied, post #34 · Sourcing › Vendor reports · 9 Jul 2026 · 7 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
Request: a per-category review queue Replied, post #75 · Meta › Feature requests · 2 Jul 2026 · 1 like Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
-
Retatrutide mass and identity: what a report should show Replied, post #8 · Compounds › Retatrutide · 2 Jul 2026 · 1 like Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
How shortages have affected compounding permissions Replied, post #9 · Access › Shortages · 1 Jul 2026 · 6 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #48 · Compounds › Oral incretins · 18 Jun 2026 · 28 likes post #47 is right about the mechanism and I think understates the practical bit. Trial adherence in an oral trial with strict administration requirements is genuinely…
-
Bioimpedance and hydration: why the number moves Replied, post #62 · Outcomes › Body composition · 18 Jun 2026 · 18 likes Picking up post #59: that is the part I would want checked first. Precision versus accuracy: the precision you need depends on what question you are answering. "Am I…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #4 · Practice › Side effects · 10 Jun 2026 · 0 likes This follows post #2 rather than contradicting it. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme…
-
Official shortage notices and what they authorise Replied, post #96 · Access › Shortages · 9 Jun 2026 · 3 likes This follows post #93 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #5 · Access › International · 8 Jun 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Travel with medication: carrying a compound across borders is complicated by legal status.…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #92 · Sourcing › Red flags · 6 Jun 2026 · 1 like Worth separating two things that post #88 runs together. Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get…